Entering text into the input field will update the search result below

(PWRME.OB, KFRC, HILL, PACR, CLNO) Stocks in Review by Stock-PR.com

Apr. 26, 2011 11:01 AM ET
Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors.

<p align="center">Stock-PR Reporting</p>
<p align="center"><a title="Stock-PR website" href="stock-pr.com&quot; target="_blank"><img class="alignnone size-full wp-image-2414" title="stockpr_logo-site" alt="stockpr_logo-site" src="stock-pr.com/img/stockpr_logo-site.jpg&quot; /></a></p>
<p align="center"> </p>
<p align="center"><strong><a title="free stock alerts, best stock alerts, hot stock alerts, stock picks, best stock picks, free stock picks" href="pennyomega.com/?page_id=835&quot;></a></strong></p>
<p align="center"><strong><span style="COLOR: black">FREE Daily Stock Alerts From Stock-PR.com</span></strong></p>
<p style="TEXT-ALIGN: center"> </p>
<p align="center"><a title="free stock alerts, best stock alerts, hot stock alerts, stock picks, best stock picks, free stock picks" href="stock-pr.com/?page_id=1085&quot;></a></p>
<p align="center"><span style="COLOR: black"><strong><span style="COLOR: black"><strong><span style="COLOR: rgb(0,128,255)"><span style="COLOR: rgb(0,128,255)"><a title="stock-pr sign up" href="stock-pr.com/signup&quot; target="_blank"><img height="90" alt="chartstockalert" src="pennyomega.com/img/chartstockalert.jpg&quot; width="360" /></a></span></span></strong></span></strong></span></p>
<p align="center"> </p>
<p><span style="COLOR: black"><span style="COLOR: black"><span style="COLOR: rgb(0,128,255)"><span style="COLOR: rgb(0,128,255)"><font color="black"><strong><img style="WIDTH: 176px; HEIGHT: 76px" height="63" alt="power3" hspace="0" src="pennyomega.com/img/power3.png&quot; width="152" align="bottom" border="0" /> Power3 Medical Products, Inc. (PWRME.OB)<br />
<br /></strong>The NuroPro Blood Test is Power3's diagnostic tool for the early detection of Neurodegenerative diseases. The analysis is designed as a tool for physicians to diagnose various degenerative diseases of the brain and nervous system. The test involves monitoring the concentration of 59 proteins in blood serum to accurately detect and distinguish between Alzheimer's disease, ALS (Lou Gehrig's disease), and Parkinson's disease. Early detection of these diseases will allow physicians to intervene at an early stage to delay disease progression, potentially allowing patients to outlive their debilitating symptoms.<br />
<br />
Alzheimer's disease (AD) is a slowly progressive disease of the brain that is characterized by impairment of memory and eventually by disturbances in reasoning, planning, language, and perception. Many scientists believe that Alzheimer's disease results from an increase in the production or accumulation of a specific protein (beta-amyloid protein) in the brain that leads to nerve cell death.</font></span></span></span></span></p>
<p><span style="COLOR: black"><span style="COLOR: black"><span style="COLOR: rgb(0,128,255)"><span style="COLOR: rgb(0,128,255)"><font color="black"><strong>Power3 Medical Products, Inc.</strong> is a leading bio-technology company focused on the development of innovative diagnostic tests in the fields of cancer and neurodegenerative diseases such as Alzheimer's disease, Parkinson's disease and amyotrophic lateral sclerosis (commonly known as ALS or Lou Gehrig's disease). Power3 applies proprietary methodologies to discover and identify protein biomarkers associated with diseases. Through these processes, Power3 has developed a portfolio of products including BC-SeraPro™, a proteomic blood serum test for the early detection of breast cancer for which it has completed Phase I clinical trials, and NuroPro®, a proteomic blood serum test for the detection of neurodegenerative diseases, including Alzheimer's, Parkinson's, and ALS diseases, for which it is currently engaged in Phase II clinical trials. These tests are designed to analyze an individual's proteins to detect the presence of disease, a patient's disease progression, a patient's response to a particular drug, and the mechanisms of disease present in the patient for optimal targeted therapy.</font></span></span></span></span></p>
<p><span style="COLOR: black"><span style="COLOR: black"><span style="COLOR: rgb(0,128,255)"><span style="COLOR: rgb(0,128,255)"><font color="black">Please visit Power3 Medical Products, Inc website</font> <a href="www.power3medical.com&quot;><font color="black">www.power3medical.com&lt;/font></a><font color="black">.</font></span></span></span></span></p>
<p><span style="COLOR: black"><font color="black">**************************************<br />
<br />
<strong>Kforce Inc. (Nasdaq:KFRC)</strong> on Tuesday, May 3, 2011 will release first quarter results post-market and host a conference call to discuss the results. The call will begin at 5:00 p.m. EDT. The dial-in number is (877) 344-3890. The conference passcode is Kforce. The replay of the call will be available from 7:00 p.m. EDT. Tuesday, May 3 to May 19, 2011 by dialing (800) 642-1687, passcode 24319517.This call is being webcast by Shareholder.com and can be accessed at Kforce's web site at</font> <a href="www.kforce.com&quot;><font color="black">kforce.com&lt;/font></a> <font color="black">(select "Investor Relations"). The webcast replay will be available until May 19, 2011.<br />
<br />
Kforce Inc., together with its subsidiaries, provides professional and technical specialty staffing services and solutions to the federal government, state and local governments, local and regional companies, and small to mid-sized companies in the United States. It offers flexible staffing services and solutions on temporary and full-time basis, as well as provides search services.<br />
<br />
*******************************************<br />
<br />
<strong>Dot Hill Systems Corp. (Nasdaq:HILL)</strong> announced it is scheduled to release first quarter 2011 financial results after the close of the market on May 5, 2011. Dot Hill's first quarter 2011 financial results conference call is scheduled to take place on Thursday, May 5, 2011 at 4:30 p.m. ET. Please join us for a live audio webcast at</font> <a href="www.dothill.com&quot;><font color="black">dothill.com&lt;/font></a> <font color="black">in the Investor Relations section. If you prefer to join via telephone, please dial 877-303-3196 (U.S.) or 408-427-3864 (International) at least five minutes prior to the start of the call. A replay of the webcast is scheduled to be available for one week on the Dot Hill web site following the conference call. For a telephone replay, dial 800-642-1687 (U.S.) or 706-645-9291 (International) and enter conference ID# 61982919.<br />
<br />
Dot Hill Systems Corp. provides entry-level and midrange storage systems and enterprise server software for organizations requiring networked storage and data management solutions in open systems architecture.<br />
<br />
****************************************<br />
<br />
<strong>Pacer International Inc. (Nasdaq:PACR)</strong> will hold its first quarter financial results live conference call with audio-only Webcast for investors, analysts, media, and other interested parties at 8:30 a.m. ET on Thursday, April 28, 2011. Chairman and CEO, Dan Avramovich; Chief Financial Officer, John Hafferty; and Chief Commercial Officer, Mike Burns will discuss the company's 2011 first quarter and current prospects. The actual financial results will be released via Business Wire prior to the call on Thursday, April 28.<br />
<br />
Pacer International, Inc. operates as an asset-light freight transportation and third-party logistics provider in North America. It operates in two segments, Intermodal and Logistics. The Intermodal segment provides rail brokerage, stacktrain, and local cartage services. This segment also offers ramp-to-ramp and door-to-door services.<br />
<br />
<p> </p>
<p><font color="black"><strong><img style="WIDTH: 292px; HEIGHT: 80px" alt="pennyomega.com/img/clno.jpg&quot; hspace="0" src="pennyomega.com/img/clno.jpg&quot; align="bottom" border="0" /> Cleantech Transit Inc. (OTCPK:CLNO)<br /></strong><br />
Municipal sewage contains organic biomass solids, and many wastewater treatment plants use anaerobic digestion to reduce the volume of these solids. Anaerobic digestion stabilizes sewage sludge and destroys pathogens. Sludge digestion produces biogas containing 60-percent to 70-percent methane. Most wastewater treatment plants that use anaerobic digesters burn the gas for heat to maintain digester temperatures and to heat building space. Unused gas is burned off as waste but could be used for fuel in an engine-generator or fuel cell to produce electric power.</font></p>
<p><font color="black"><strong>Cleantech Transit Inc.</strong> was founded to capitalize on technology advances and manufacturing opportunities in the growing clean energy public transportation sector. The Company has expanded its focus to invest directly in specific green projects. Recognizing the many economic and operational advances of converting wood waste into renewable sources of energy, Cleantech has selected to invest in Phoenix Energy (</font><a href="www.phoenixenergy.net&quot;><font color="black">phoenixenergy.net&lt;/font></a><font color="black">). This project can generate shareholder returns as well benefit the Company's manufacturing clients worldwide. Cleantech Transit Inc. is in the business of producing and conserving power. It produces and sells clean electricity globally, with a focus on sustainable energies using renewable resources such as Geothermal, Solar and Wind.<br />
<br />
<strong>Cleantech Transit Inc.</strong> recently announced that funding to be provided to Phoenix Energy for the commercialization of a 500 Kilowatt biomass gasification plant should be eligible to apply for a renewable energy cash back incentive program offered by the U.S. Federal Government. Once the final interconnect process and applications are complete the grant should be received within 60 days. The 5-year grant vesting period, means all parties must remain owner of record for that length of time, underscoring Cleantech and its partners' commitment to this project and the host community. The U.S. Treasury's cash grant program was created to provide funding, in lieu of tax credits, for the development of clean energy projects and clean tech jobs nationwide. The Merced facility has already employed several individuals, both for the construction phase and subsequent plant operations once in service.As Company announced, the full commercial operation of the first plant is expected to be completed during the second quarter of 2011.</font></p>
<p><font color="black">Please visit Cleantech Transit, Inc. website</font> <a href="www.cleantechtransitinc.com&quot;><font color="black">cleantechtransitinc.com&lt;/font></a><font color="black">.<br /></font></p>
<p align="center"> </p>
<p align="center">**************************************************************</p>
<p align="center"><strong>THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!</strong></p>
<p><strong><font color="blue"><font color="red">Disclaimer:</font> Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Stock-PR.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold Stock-PR.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (<font color="red">Read more at <a href="stock-pr.com/?page_id=40&quot; target="_blank"><font color="red">stock-pr.com/disclaimer&lt;/font></a></font>).</font></strong><span style="COLOR: red"><span style="COLOR: red"><strong><font color="blue">Crown Equity Holdings Inc. (OTCPK:CRWE) is a newswire as well as an IR and PR firm. Crown Equity Holdings Inc. (OTCPK:CRWE), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (OTCPK:CRWE) advertises for a particular client, Crown Equity Holdings Inc. (OTCPK:CRWE) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (OTCPK:CRWE), if paid in stock, can and may sell those securities during the advertising period.</font><font color="red">Crown Equity Holdings Inc. (OTCPK:CRWE) has received 1,000,000 shares 144 restricted stocks for IT department services and 2,000,000 shares (free trade) for 12 months of video production from Power 3 Medical Products Inc. (PWRME.OB). Crown Equity Holdings Inc. (OTCPK:CRWE) anticipates receiving 2,000,000 shares of 144 restricted stocks from the company for 12 months of advertisement services for Cleantech Transit, Inc. (OTCPK:CLNO).</font></strong></span></span></p>
<p> </p>
<p> </p>
<p align="center">Sign Up For Free Stock Alerts At <a href="stock-pr.com/signup&quot; target="_blank">stock-pr.com/signup&lt;/a></p>
<p align="center"><a href="www.crownequityholdings.com&quot; target="_blank"><img alt="stock-pr.com/img/stock-pr_buscard.jpg&quot; src="stock-pr.com/img/stock-pr_buscard.jpg&quot; /></a></p>

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

Recommended For You

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.